Minimal clinically important difference of the EORTC QLQ-CIPN20 for worsening peripheral neuropathy in patients receiving neurotoxic chemotherapy
Journal article
Yeo, F., Ng, C.C., Loh, K.W.J., Molasiotis, A., Cheng, H.L., Au, J.S.K., Leung, K.T., Li, Y.C., Wong, K.-H., Suen, L., Chan, C.W., Yorke, J., Farrell, C., Bandla, A., Ang, E., Lopez, V., Sundar, R. and Chan, A. 2019. Minimal clinically important difference of the EORTC QLQ-CIPN20 for worsening peripheral neuropathy in patients receiving neurotoxic chemotherapy. Supportive care in cancer. 27, p. 4753–4762. https://doi.org/10.1007/s00520-019-04771-8
Authors | Yeo, F., Ng, C.C., Loh, K.W.J., Molasiotis, A., Cheng, H.L., Au, J.S.K., Leung, K.T., Li, Y.C., Wong, K.-H., Suen, L., Chan, C.W., Yorke, J., Farrell, C., Bandla, A., Ang, E., Lopez, V., Sundar, R. and Chan, A. |
---|---|
Year | 2019 |
Journal | Supportive care in cancer |
Journal citation | 27, p. 4753–4762 |
Publisher | Springer |
Digital Object Identifier (DOI) | https://doi.org/10.1007/s00520-019-04771-8 |
Output status | Published |
Publication dates | 2019 |
Publication process dates | |
Deposited | 23 May 2025 |
Permalink -
https://repository.derby.ac.uk/item/qy402/minimal-clinically-important-difference-of-the-eortc-qlq-cipn20-for-worsening-peripheral-neuropathy-in-patients-receiving-neurotoxic-chemotherapy
28
total views0
total downloads13
views this month0
downloads this month